Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study
Annabelle Bédard, Xavier Basagaña, Josep M. Antó, et al.
Clinical and Translational Allergy (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Guideline on allergen immunotherapy in IgE-mediated allergic diseases
Oliver Pfaar, Tobias Ankermann, Matthias Augustin, et al.
Allergologie select (2022) Vol. 6, Iss. 01, pp. 167-232
Open Access | Times Cited: 83
Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold: An ARIA‐EAACI‐GA2LEN consensus
Jan Hagemann, Gabrielle L. Onorato, Marek Jutel, et al.
Allergy (2021) Vol. 76, Iss. 8, pp. 2354-2366
Open Access | Times Cited: 64
One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence
Oliver Pfaar, Jean Bousquet, Stephen R. Durham, et al.
Allergy (2021) Vol. 77, Iss. 2, pp. 454-468
Open Access | Times Cited: 64
Development and validation of combined symptom‐medication scores for allergic rhinitis*
Bernardo Sousa‐Pinto, Luís Filipe Azevedo, Marek Jutel, et al.
Allergy (2021) Vol. 77, Iss. 7, pp. 2147-2162
Open Access | Times Cited: 57
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air® real‐world data
Bernardo Sousa‐Pinto, Ana Sá‐Sousa, Rafael José Vieira, et al.
Allergy (2022) Vol. 77, Iss. 9, pp. 2699-2711
Open Access | Times Cited: 41
Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air®approach
Jean Bousquet, Josep M Antó, Bernardo Sousa‐Pinto, et al.
Clinical and Translational Allergy (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 34
Hot topics in allergen immunotherapy, 2023: Current status and future perspective
Magdalena Zemelka‐Wiącek, Ioana Agache, Cezmi A. Akdiş, et al.
Allergy (2023) Vol. 79, Iss. 4, pp. 823-842
Open Access | Times Cited: 27
MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases
Jean Bousquet, Bernardo Sousa‐Pinto, Josep M. Antó, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 8, pp. 2010-2016.e7
Open Access | Times Cited: 8
Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐air Study
Bernardo Sousa‐Pinto, Elı́sio Costa, Rafael José Vieira, et al.
Clinical & Experimental Allergy (2025)
Open Access | Times Cited: 1
Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK‐air®
Bernardo Sousa‐Pinto, Patrik Eklund, Oliver Pfaar, et al.
Clinical and Translational Allergy (2021) Vol. 11, Iss. 7
Open Access | Times Cited: 45
The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis
Jean Bousquet, Mondher Toumi, Bernardo Sousa‐Pinto, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 11, pp. 2878-2888
Open Access | Times Cited: 27
Academic Productivity of Young People With Allergic Rhinitis: A MASK-air Study
Rafael José Vieira, N. Pham‐Thi, Josep M. Antó, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 11, pp. 3008-3017.e4
Open Access | Times Cited: 25
Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach – ARIA‐EAACI Task Force Report
Jean Bousquet, Mohamed H. Shamji, Josep M. Antó, et al.
Allergy (2023) Vol. 78, Iss. 7, pp. 1758-1776
Open Access | Times Cited: 16
Comparison of rhinitis treatments using MASK‐air® data and considering the minimal important difference
Bernardo Sousa‐Pinto, Holger J. Schünemann, Ana Sá‐Sousa, et al.
Allergy (2022) Vol. 77, Iss. 10, pp. 3002-3014
Open Access | Times Cited: 21
Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities
Bernardo Sousa‐Pinto, Aram Antó, Markus Berger, et al.
Clinical and Translational Allergy (2022) Vol. 12, Iss. 11
Open Access | Times Cited: 21
Impact of allergic symptoms on work productivity in allergic rhinitis: A MASK-air direct patient data study
Rafael José Vieira, Ana Margarida Pereira, Maciej Kupczyk, et al.
Allergology International (2025)
Open Access
Factors that influence user adherence of the Mask‐air® application
Anna Szylling, Bolesław Samoliński, Filip Raciborski, et al.
Clinical and Translational Allergy (2025) Vol. 15, Iss. 4
Open Access
Automatic market research of mobile health apps for the self‐management of allergic rhinitis
Aram Antó, Bernardo Sousa‐Pinto, Heather J. Zar, et al.
Clinical & Experimental Allergy (2022) Vol. 52, Iss. 10, pp. 1195-1207
Open Access | Times Cited: 16
Mobile health app for monitoring allergic rhinitis and asthma in real life in Lithuanian MASK‐air users
Violeta Kvedarienė, Gabija Biliute, Gabija Didžiokaite, et al.
Clinical and Translational Allergy (2022) Vol. 12, Iss. 9
Open Access | Times Cited: 16
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK‐air® longitudinal study
Bernardo Sousa‐Pinto, Holger J. Schünemann, Ana Sá‐Sousa, et al.
Allergy (2022) Vol. 78, Iss. 4, pp. 968-983
Open Access | Times Cited: 15
Allergen immunotherapy in MASK‐air users in real‐life: Results of a Bayesian mixed‐effects model
Bernardo Sousa‐Pinto, Luís Filipe Azevedo, Ana Sá‐Sousa, et al.
Clinical and Translational Allergy (2022) Vol. 12, Iss. 3
Open Access | Times Cited: 14
Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app
Jean Bousquet, Bernardo Sousa‐Pinto, Josep M. Antó, et al.
Pulmonology (2022) Vol. 29, Iss. 4, pp. 292-305
Open Access | Times Cited: 14
Effects of allergen immunotherapy in the MASK‐air study: a proof‐of‐concept analysis
Oliver Pfaar, Bernardo Sousa‐Pinto, Philippe Devillier, et al.
Allergy (2021) Vol. 76, Iss. 10, pp. 3212-3214
Open Access | Times Cited: 19
Implementation of the MASK-Air® App for Rhinitis and Asthma in Older Adults: MASK@Puglia Pilot Study
Maria Teresa Ventura, Antonio Francesco Maria Giuliano, R. Buquicchio, et al.
International Archives of Allergy and Immunology (2021) Vol. 183, Iss. 1, pp. 45-50
Open Access | Times Cited: 18
Cutoff Values of MASK-air Patient-Reported Outcome Measures
Bernardo Sousa‐Pinto, Ana Sá‐Sousa, Rafael José Vieira, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 11, Iss. 4, pp. 1281-1289.e5
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top